Chromocell Therapeutics Seeks $8.7 Million In Micro-IPO

• Chromocell Therapeutics, a Phase 1 biotech developing a non-addictive pain blocker using a sodium ion channel
• HQ North Brunswick, New Jersey
• https://chromocell.com/

 

Chromocell Therapeutics Corporation has filed for an $8.7 million IPO to develop its treatment for chronic pain conditions.

The company's lead compound is being prepared for a Phase 2a study for erythromelalgia patients with a genetic component.

The global market for erythromelalgia treatment is estimated to reach $3.5 billion by 2032, driving potential growth for Chromocell.

==Maison Solutions (MSS) began trading on the Nasdaq on Thur 5 Oct 23

Maison Solutions Inc. is a fast-growing specialty grocery retailer offering traditional Asian food and merchandise to modern U.S. consumers, particularly to members of Asian-American communities.

• Headquarters: Monterey Park, CA
• Founded: 2019
• maisonsolutionsinc.com

Instacart (CART) began trading on the Nasdaq on Tue 19 Sept 23

Instacart, the grocery-delivery company that saw its business boom during the pandemic, priced its long-awaited IPO at $30 a share on Monday, , at the high end of the revised $28-30 expected range.

It will become the first notable venture-backed tech company to hit the U.S. public market since December 2021.

Instacart priced 22.0 mln share IPO at $30.00 per share

Opened for trading at $42, ended the day about 20% below its opening price of $42 (33.70 +3.70)

Ticker:  CART

The 11-year-old company, which delivers groceries from chains including Kroger, Costco and Wegmans, had to drop its stock price dramatically to make it appealing for public market investors. In early 2021, at the height of the Covid pandemic, Instacart raised money at a $39 billion valuation, or $125 a share, from prominent venture firms like Sequoia Capital and Andreessen Horowitz, along with big asset managers Fidelity and T. Rowe Price.

Instacart co-founder Apoorva Mehta owns shares worth over $800 million, and is selling a small portion of them in the IPO. Mehta has been executive chair since the company appointed ex-Facebook executive Fidji Simo as his successor as CEO in 2021. Mehta is resigning from the board in conjunction with the IPO, and Simo is assuming the role of chair.